产品货号：
JN1710
中文名称：
重组人激肽释放酶(Kallikrein 11)(KLK11)
英文名称：
Recombinant Human Kallikrein 11
产品规格：
10μg|50μg|500μg|1mg
发货周期：
1～3天
产品价格：
询价
本品由我们的哺乳动物细胞表达系统制备而成，目的基因编码的Glu19-Asn250在C端含有His标签。
Kallikrein 11质量控制：＞95%(还原性SDS-PAGE)
Kallikrein 11制剂：液体
Kallikrein 11保存：收到货后请置于-20℃，可保存6个月，避免反复冻融。
关于Kallikrein 11：
Human Kallikrein 11 (KLK11) is a member of tissue kallikrein family which are extracellular serine proteases consisting of 15 members. Two isoforms of KLK11 are differentially expressed. Isoform 1 is predominantly expressed in brain and isoform 2 is preferentially expressed in prostate. Isoform 1 consists of a signal peptide,a short pro peptide and the mature chain.Isoform 2 contains an extra 32 amino acid N terminal to full-length isoform 1.KLK11 is a novel marker for ovarian and prostate cancer carcinomas. KLK11 can be activated by thermolysin and is active against a thioester substrate.
相关搜索：重组人激肽释放酶(Kallikrein 11)(KLK11)，Recombinant Human Kallikrein 11
Kallikrein 11质量控制：＞95%(还原性SDS-PAGE)
Kallikrein 11制剂：液体
Kallikrein 11保存：收到货后请置于-20℃，可保存6个月，避免反复冻融。
关于Kallikrein 11：
Human Kallikrein 11 (KLK11) is a member of tissue kallikrein family which are extracellular serine proteases consisting of 15 members. Two isoforms of KLK11 are differentially expressed. Isoform 1 is predominantly expressed in brain and isoform 2 is preferentially expressed in prostate. Isoform 1 consists of a signal peptide,a short pro peptide and the mature chain.Isoform 2 contains an extra 32 amino acid N terminal to full-length isoform 1.KLK11 is a novel marker for ovarian and prostate cancer carcinomas. KLK11 can be activated by thermolysin and is active against a thioester substrate.
相关搜索：重组人激肽释放酶(Kallikrein 11)(KLK11)，Recombinant Human Kallikrein 11